Vanda Pharmaceuticals, Inc. (VNDA)
5.985
-0.10
(-1.56%)
USD |
NASDAQ |
May 19, 16:00
5.985
0.00 (0.00%)
After-Hours: 19:15
Vanda Pharmaceuticals Total Liabilities (Quarterly) : 152.76M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AnaptysBio, Inc. | 316.94M |
| Amgen, Inc. | 83.31B |
| Gossamer Bio, Inc. | 290.38M |
| BridgeBio Pharma, Inc. | 3.640B |
| Geron Corp. | 305.01M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 433.52M |
| Shareholders Equity (Quarterly) | 280.76M |
| Debt to Equity Ratio | 0.0466 |
| Current Ratio | 2.162 |
| Net Debt Paydown Yield | -0.03% |